There is currently no consensus on how to treat patients with a suboptimal biochemical response to UDCA.
目前,对udca应答欠佳患者的治疗方法尚不确定。
Ursodeoxycholic acid (UDCA) is the only safe and effective drug for the treatment of PBC proven by randomized controlled clinical trials.
熊去氧胆酸(UDCA)是惟一经随机对照临床试验证实的治疗PBC安全有效的药物。
ConclusionsAdministration of UDCA following cholangioenterostomy is safe, and it can significantly reduce the occurrence rate of retrograde biliary tract infection.
结论:胆肠吻合术后应用udca安全,可显著降低术后胆道逆行感染的发生率。
There are two goals, to determine: 1) whether TIW is frequently associated with rejection; and 2) whether UDCA decreases the risk of liver disease (both rejection and recurrence) after TIW.
本研究有两个目的:一、判定TIW是否与移植排斥反应密切相关;二、判定UDCA是否降低TIW后的肝病(包括排斥反应和复发)发病风险。
There are two goals, to determine: 1) whether TIW is frequently associated with rejection; and 2) whether UDCA decreases the risk of liver disease (both rejection and recurrence) after TIW.
本研究有两个目的:一、判定TIW是否与移植排斥反应密切相关;二、判定UDCA是否降低TIW后的肝病(包括排斥反应和复发)发病风险。
应用推荐